首页 | 本学科首页   官方微博 | 高级检索  
     

尼美舒利治疗骨关节炎和类风湿关节炎的临床疗效
引用本文:张晓 杨岫岩. 尼美舒利治疗骨关节炎和类风湿关节炎的临床疗效[J]. 中国新药与临床杂志, 1998, 17(5): 261-263
作者姓名:张晓 杨岫岩
作者单位:[1]中山医科大学第三附属医院风湿内科 [2]中山医科大学第一附属医院风湿内科
摘    要:
目的:了解尼美舒利治疗骨关节炎(OA)及类风湿关节炎(RA)的疗效及副作用。方法:尼美舒利组:OA和RA各30例,予尼美舒利100mg,po,bid;对照组:OA和RA各30例,予双氯芬酸25mg,po,tid,或萘普生250mg,po,bid,观察4wk。结果:治疗前后2组病人各项临床指标均有明显改善;而实验室指标改善不明显(P>0.05)。2组总有效率分别是88%和85%,差别无显著意义;副作用发生率分别为3%和13%,差别有显著意义(P<0.05)。结论:尼美舒利抗炎镇痛疗效肯定,副作用较少,是一种安全性较佳的非甾体类消炎止痛药。

关 键 词:尼美舒利;骨关节炎;类风湿关节炎;非甾类消炎药;双氯芬酸;萘普生

Clinical effects of nimesulide in treating osteoarthritis and rheumatoid arthritis
ZHANG Xiao. Clinical effects of nimesulide in treating osteoarthritis and rheumatoid arthritis[J]. Chinese Journal of New Drugs and Clinical Remedies, 1998, 17(5): 261-263
Authors:ZHANG Xiao
Abstract:
AIM: To study the clinical effects and side effects of nimesulide in treating osteoarthiritis(OA) and rheumatoid arthritis (RA). METHODS: Sixty OA patients and sixty RA patients were randomly divided into two groups, nimesulide group (30 OA patients and 30 RA patients) received nimesulide 100 mg, po, bid, for 4 wk and control group (30 OA patients and 30 RA patients) were treated with diclofenac 25 mg, po, tid or naproxen 250 mg, po, bid for 4 wk. RESULTS: All clinical indexes were markedly improved (P<0.05 or 0.01), but laboratory indices not improved (P>0.05), after treatment. The total effective rates were 88% in nimesulied group, and 85% in control group. No significant difference existed between the two groups. The side effects were 3% in nimesulide group and 13% in control group(P<0.05). CONCLUSION: nimesulide is a safe nonsteroidal anti_inflammatory drug.
Keywords:nimesulide  osteoarthritis  rheumatoid arthritis  non_steroidal anti_inflammatory agents  diclofenac  naproxen
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号